Tetracycline Transcriptional Silencer Tightly Controls Transgene Expression After In Vivo Intramuscular Electrotransfer: Application to Interleukin 10 Therapy in Experimental Arthritis
The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
The doxycycline (Dox)-inducible reverse tetracycline transactivator (rtTA) is often used to control gene expression. However, the Tet-on system displays a high background activity. To overcome this unregulated expression we used the tetracycline-dependent transcriptional silencer (tTS), which binds the tetO inducible promoter in the absence of Dox. Controlled gene expression was analyzed in vivo by delivering combinations of Dox-regulated luciferase reporter construct, rtTA, and tTS expression plasmids into mouse muscle, using electrotransfer. Elevated luciferase expression levels were observed in the absence of doxycycline, and a 10-fold induction was obtained after drug administration. In contrast, when tTS was added, background expression was dramatically lowered by three to four orders of magnitude, and induction was maintained. The tTS system was then used to control expression of a therapeutic gene in experimental arthritis. DBA/1 mice were coinjected with plasmids encoding the antiinflammatory interleukin-10 cytokine under the control of the tetO promoter, the rtTA, and the tTS. Electrotransfer resulted in a dose-dependent increase in IL-10 expression, maintained over a 3-month period, and significant inhibitory effects on collagen-induced arthritis. We conclude that the use of tTS significantly improves the utility of the rtTA system for somatic gene transfer by reducing background activity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tight control of gene expression in mammalian cells by tetracycline-responsive promoters.
Gossen, M., & Bujard, H. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.12.5547 · Cited by 4,943 · cited 2×
“Tetracycline (Tc) binds tTA, inducing a conformational change that prevents it from binding to the tetO , and thus switches the transgene expression off (Gossen and Bujard, 1992).”
Transcriptional Activation by Tetracyclines in Mammalian Cells
Gossen, M., Freundlieb, S., Bender, G., Müller, G., Hillen, W., & Bujard, H. (1995) · Science · doi:10.1126/science.7792603 · Cited by 2,488 · cited 2×
“The tetracycline-controlled expression systems (Gossen and Bujard, 1992; Gossen et al. , 1995) are widely used to regulate gene expression and were shown to function in different organisms (Fishman et al. , 1994; Wein-mann et al. , 1994; Kistner et al. , 1996; Gari et al. , 1997; Gi-1 rard et al. ,…”
Urlinger, S., Baron, U., Thellmann, M., Hasan, M. T., Bujard, H., & Hillen, W. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.130192197 · Cited by 928
Recombinant AAV-mediated delivery of a tet-inducible reporter gene to the rat retina
McGee Sanftner, L. H., Rendahl, K. G., Quiroz, D., Coyne, M., Ladner, M., Manning, W. C., & Flannery, J. G. (2001) · Molecular Therapy · doi:10.1006/mthe.2001.0308 · Cited by 94 · cited 1×
“The tTS has been used to regulate gene expression in single muscle fibers in rats (Sander et al. , 2000), in transgenic mice (Zhu et al. , 2001), in the rat retina (McGee Sanftner et al. , 2001), and more recently in mouse skeletal muscle (Rendahl et al. , 2002).”
Cited by
Bouffi, C., Bony, C., Courties, G., Jorgensen, C., & Noël, D. (2010) · PLoS ONE · doi:10.1371/journal.pone.0014247 · Cited by 383
Self-citationDNA electrotransfer: its principles and an updated review of its therapeutic applications
André, F., & Mir, L. M. (2004) · Gene Therapy · doi:10.1038/sj.gt.3302367 · Cited by 292
Regulatable gene expression systems for gene therapy applications: progress and future challenges
Goverdhana, S., Puntel, M., Xiong, W., Zirger, J. M., Barcia, C., Curtin, J. F., Soffer, E. B., Mondkar, S., King, G. D., Hu, J., et al. (2005) · Molecular Therapy · doi:10.1016/j.ymthe.2005.03.022 · Cited by 283
“11 reporter genes in a model of arthritis [136], most current research is now focused on the robust TetON regulatory system for treating this disease [137].”
BackgroundBerens, C., & Hillen, W. (2003) · European Journal of Biochemistry · doi:10.1046/j.1432-1033.2003.03694.x · Cited by 261
Ginhoux, F., Turbant, S., Gross, D. A., Poupiot, J., Marais, T., Lone, Y., Lemonnier, F. A., Firat, H., Perez, N., Danos, O., et al. (2004) · Molecular Therapy · doi:10.1016/j.ymthe.2004.05.012 · Cited by 49
Self-citation
Metadata
- Authors
- Perez, N., Plence, P., Millet, V., Greuet, D., Minot, C., Noel, D., Danos, O., Jorgensen, C., & Apparailly, F.
- Venue
- Human Gene Therapy
- Publisher
- SAGE Publications
- Published
- 2002-12-10
- Volume
- 13
- Issue
- 18
- Pages
- 2161-2172
- ISSN
- 1043-0342 (ISSN-L)
- 1557-7422
- OpenAlex
- W1993980992
- Cited by
- 70
- References
- 4
- FWCI
- 3.35
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Tetracycline Transcriptional Silencer Tightly Controls Transgene Expression After In Vivo Intramuscular Electrotransfer: Application to Interleukin 10 Therapy in Experimental Arthritis. https://app.cochat.ai/papers/10.1089/104303402320987851
- The paper
- Perez, N., Plence, P., Millet, V., Greuet, D., Minot, C., Noel, D., Danos, O., Jorgensen, C., & Apparailly, F. (2002). Tetracycline Transcriptional Silencer Tightly Controls Transgene Expression After In Vivo Intramuscular Electrotransfer: Application to Interleukin 10 Therapy in Experimental Arthritis. Human Gene Therapy. https://doi.org/10.1089/104303402320987851
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.